Biography

Magdalena Tary-Lehmann is Co-Founding Scientist and Chief Scientific Officer for Cellular Technology Limited (CTL). She received her MD and PhD from the University of Tübingen, Germany. Her postdoctoral training in Immunology was at the University of California, Los Angeles. She moved after that to Case Western Reserve University, where she was awarded tenure and appointed Associate Professor in the Department of Pathology. As CEO of the contract laboratory, she oversees the performance of immunology assays in CTL’s GCP, GLP- and CLIA-compliant contract laboratory for various pharmaceutical and biotechnology clients and serves as CSO for CTL.